Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Grifols Investor Alert

GRFS, GIKLY, GIFOF, GIFLF

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Significant Losses In Grifols To Contact Him Directly To Discuss Their Options

If you suffered significant losses in Grifols stock or options and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). You may also click here for additional information: www.faruqilaw.com/GRFS.

There is no cost or obligation to you.

Cannot view this image? Visit: https://images.newsfilecorp.com/files/6455/198270_98558de164843831_001full.jpg

New York, New York--(Newsfile Corp. - February 17, 2024) - Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Grifols, S.A. ("Grifols" or the "Company") (NASDAQ: GRFS) (OTC Pink: GIKLY) (OTC Pink: GIFOF) (OTC Pink: GIFLF).

Faruqi & Faruqi is a leading minority and Woman-owned national securities law firm with offices in New York, Pennsylvania, California and Georgia.

On January 9, 2024, Gotham City Research LLC published a short-seller report on Grifols, S.A. In the report, Gotham City alleged the stock market "appears to fundamentally misunderstand the company." The report claimed that Grifols "artificially reduced leverage by consolidating earnings of units it doesn't control and has overstated profit." In addition, the report stated "GRF manipulates reported debt & EBITDA to artificially reduce reported leverage to 6x which we believe is closer to 10x-13x." The report concluded if these estimates are correct, Grifols "will face notably higher financing costs. Consequently, we believe shares are uninvestable, likely zero."

On this news, Grifols American Depositary Receipts ("ADRs") fell as much as 32%, in pre-market trading on January 9, 2024.

Attorney Advertising. The law firm responsible for this advertisement is Faruqi & Faruqi, LLP (www.faruqilaw.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter. We welcome the opportunity to discuss your particular case. All communications will be treated in a confidential manner.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/198270